Bruck syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In our patient, compound heterozygosity with PLOD2 mutations is associated with a clinical phenotype distinctive from classic BRKS2 indicating that when COL1A1 and COL1A2 mutation testing is negative for OI without congenital contractures or pterygia, atypical BRKS should be considered.
|
31472299 |
2020 |
Bruck syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in FKBP10 and PLOD2 were identified as the underlying genetic defects of Bruck syndrome.
|
29177700 |
2018 |
Bruck syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Bruck syndrome type 2 (BRKS2; MIM:609220) is a rare form of autosomal recessive OI caused by biallelic PLOD2 variants and is associated with congenital joint contractures with pterygia.
|
29178448 |
2018 |
Bruck syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Bruck Syndrome is a connective tissue disease associated with inactivating mutations in lysyl hydroxylase 2 (LH2/PLOD2) or FK506 binding protein 65 (FKBP65/FKBP10).
|
28378777 |
2017 |
Bruck syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Novel mutations in FKBP10 and PLOD2 cause rare Bruck syndrome in Chinese patients.
|
25238597 |
2014 |
Bruck syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The phenotype overlaps with that seen with mutations in PLOD2 (Bruck syndrome II), which encodes LH2, the enzyme that hydroxylates the telopeptide lysyl residues.
|
22949511 |
2013 |
Bruck syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Thus, PLOD2 in addition to causing BS is also associated with AR-OI phenotypes of variable severity.
|
22689593 |
2012 |
Bruck syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Because of (i) absence of COL1A1/2 mutations, (ii) a consanguineous pedigree with a similarly affected sibling and (iii) the existence of congenital joint contractures with absence of recessive variants in PLOD2, mutation analysis was performed of the FKBP10 gene, recently associated with Bruck syndrome and/or recessive OI.
|
22085994 |
2012 |
Bruck syndrome
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
Thus, PLOD2 in addition to causing BS is also associated with AR-OI phenotypes of variable severity.
|
22689593 |
2012 |
Bruck syndrome
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Thus, PLOD2 in addition to causing BS is also associated with AR-OI phenotypes of variable severity.
|
22689593 |
2012 |
Bruck syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Bruck syndrome is a recessive disorder featuring congenital contractures in addition to bone fragility; Bruck syndrome type 2 is caused by mutations in PLOD2 encoding collagen lysyl hydroxylase, whereas Bruck syndrome type 1 has been mapped to chromosome 17, with evidence suggesting region 17p12, but the gene has remained elusive so far.
|
20839288 |
2011 |
Bruck syndrome
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
The proportion of BS cases linked to 17p22 (BS type 1) or caused by mutations in PLOD2 (BS type 2) is still uncertain, and phenotypic correlations are lacking.
|
15523624 |
2004 |
Bruck syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The proportion of BS cases linked to 17p22 (BS type 1) or caused by mutations in PLOD2 (BS type 2) is still uncertain, and phenotypic correlations are lacking.
|
15523624 |
2004 |
Bruck syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17.
|
9927692 |
1999 |